---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-26-001173"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2026-07-15T14:38:08+00:00"
generated_at: "2026-07-15T14:39:14.160568+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Lipella Pharmaceuticals files Chapter 11, sells substantially all assets to XRAIY LLC

## Summary
- Filed Chapter 11 on March 30, 2026 in Western District of Pennsylvania.
- Entered Asset Purchase Agreement with XRAIY LLC on May 14, 2026 to sell substantially all assets.
- Bankruptcy Court approved sale on June 4, 2026 via Sale Order.
- Company warns common stock trading is highly speculative; recovery for shareholders uncertain.
- Sale is free and clear of liens, claims, and encumbrances.

## SEC filing metadata
- accession: 0001753926-26-001173
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2026-07-15T14:38:08+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 1.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392626001173/0001753926-26-001173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392626001173/g085807_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-26-001173
- JSON: https://secwatch.observer/filing/0001753926-26-001173.json
- Plain text: https://secwatch.observer/filing/0001753926-26-001173.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.